The proposed study is designed to test the hypothesis that in human obesity, the balance of pro- and anti-inflammatory T cells in fat tissue is in fact related to macrophage phenotype and insulin resistance, and how it is related. This study is needed to confirm whether conclusions based on studies of visceral adipose tissue in mice are indeed applicable to humans. We also want to determine the relationship between insulin resistance/hyperinsulinemia and ability to lose weight in obese individuals.
Previous studies have found convincing evidence of the relationship between insulin resistance, T cell profiles, macrophage profiles and inflammation of the fat cells. This study will add human subjects to that body of evidence. Overview Aim 1: Test the hypothesis that the balance of anti- inflammatory vs proinflammatory T cells is protective for systemic insulin resistance. T cell profiles in subcutaneous and visceral tissue and blood will be compared in IR vs IS obese humans at baseline and potentially after 12 months following weight loss. Tcell profile will be evaluated for relationships with IR and inflammation, with adjustment for total body fat. Secondarily, they will be evaluated for relationship to adipose cell size. Overview Aim 2: Test the hypothesis that macrophage phenotype in adipose tissue is associated with T cell profile and IR. Frequency of macrophage phenotypes (M1 vs M2) will be analyzed in IR vs IS obese humans at baseline and potentially after 12 months following weight loss. Overview Aim 3: Testing the hypothesis insulin resistance is associated with T cell receptor phenotypes in subcutaneous and visceral tissue. IR and IS subjects will be evaluated at baseline by sequencing of expressed TCRs in paired SAT, VAT, and blood. We will determine whether TCR phenotypes are shared between different IR individuals.
Study Type
OBSERVATIONAL
Enrollment
50
Stanford University
Stanford, California, United States
T-cell profile in visceral and subcutaneous fat
Pro-inflammatory and anti-inflammatory T cell profiles in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: baseline (within 2 months prior to bariatric surgery)
T-cell profile in visceral and subcutaneous fat
Pro-inflammatory and anti-inflammatory T cell profiles in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: post-operatively (1-2 years status post bariatric surgery)
Adipose cell size associated with T cell profile and IR.
Cell size of subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: baseline (within 2 months prior to bariatric surgery)
Adipose cell size associated with T cell profile and IR.
Cell size of subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: post-operatively (1-2 years status post bariatric surgery)
Macrophage phenotype
Frequency of macrophage phenotype (M1 vs M2) in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: (Timeframe: baseline (within 2 months prior to bariatric surgery)
Macrophage phenotype
Frequency of macrophage phenotype (M1 vs M2) in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: post-operatively (1-2 years status post bariatric surgery)
T cell receptor phenotypes
Frequency of T-cell receptors in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: (Timeframe: baseline (within 2 months prior to bariatric surgery)
T cell receptor phenotypes
Frequency of T-cell receptors in subcutaneous adipose tissue and visceral adipose tissue measured via flow cytometry.
Time frame: post-operatively (1-2 years status post bariatric surgery)
Change in body weight
Percent body weight loss post bariatric surgery, accounting for insulin sensitivity, T-cell profile, cell size, and macrophage and T-cell phenotypes.
Time frame: (Timeframe: baseline (within 2 months prior to bariatric surgery)
Change in body weight
Percent body weight loss post bariatric surgery, accounting for insulin sensitivity, T-cell profile, cell size, and macrophage and T-cell phenotypes.
Time frame: post-operatively (1-2 years status post bariatric surgery)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.